Burdick Kenneth A

SEC Form 4 insider

LifeStance Health Group, Inc. ($LFST)

2 theses · first seen Aug 13, 2026

Window	Theses	Resolved	Wins	Win rate	Avg return	Median return
1d	2	2	1	50%	+0.6%	+0.6%
3d	1	1	0	0%	+1.6%	+1.6%
1w	1	1	0	0%	+3.5%	+3.5%
1m	1	1	0	0%	+6.1%	+6.1%
3m	1	1	0	0%	+17.6%	+17.6%
6m	0	0	0	—	—	—
1y	0	0	0	—	—	—

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$LFSTSEC Form 4bearish

Burdick Kenneth A · LifeStance Health Group, Inc. · 2d ago1 prior · 0% at 3mo

Sold 141,589 @ $14.51 avg · $2,054,547 · 2026-11-09

Form 4: Burdick Kenneth A sold LFST

Burdick Kenneth A (Director at LifeStance Health Group, Inc.) reported an open-market sale of 141,589 shares of LFST at an average $14.51, roughly $2,054,547, in a Form 4 filed 2026-11-12.

At post $14.15Now $14.08-0.5% since postedas of Nov 13, 4:01 PM ET

1d-0.5%

3d—

1w—

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$LFSTSEC Form 4bearish

Burdick Kenneth A · LifeStance Health Group, Inc. · 93d ago1 prior · 0% at 3mo

Sold 500,000 @ $11.51 avg · $5,755,000 · 2026-08-11

Form 4: Burdick Kenneth A sold LFST

Burdick Kenneth A (Director at LifeStance Health Group, Inc.) reported an open-market sale of 500,000 shares of LFST at an average $11.51, roughly $5,755,000, in a Form 4 filed 2026-08-13.

At post $12.22Now $14.08+15.2% since postedas of Nov 13, 4:01 PM ET

1d+1.6%

3d+1.6%

1w+3.5%

1m+6.1%

3m+17.6%

6m—

1y—

View filing on SEC.gov →

End of results.